Nacuity Pharmaceuticals
Latest round
- Series B
Last raised
- Jun 2022
Total raised
- $17M
Investors
- 3
About Nacuity Pharmaceuticals
Nacuity Pharmaceuticals, Inc.Founded in 2016 in Fort Worth, US, Nacuity Pharmaceuticals, Inc. specializes in creating therapies for retinal diseases. The company's founder, Halden Conner, has a background in pharmaceutical development.Nacuity Pharmaceuticals specializes in the development of innovative therapies aimed at addressing oxidative stress, a significant factor in blinding eye diseases and various serious chronic conditions. The core product offerings include targeted prescription therapies for conditions such as retinitis pigmentosa, cataract, and cystinosis. These therapies are designed to halt oxidative tissue damage, providing potential solutions for both rare and prevalent ophthalmic diseases, primarily targeting individuals suffering from retinal diseases and other related conditions.Nacuity Pharmaceuticals operates on a revenue model that encompasses partnerships and direct-to-consumer sales for its prescription therapies. The company engages with healthcare providers and institutions, facilitating access to its therapies aimed at treating oxidative stress-related diseases. Revenue transactions occur through established agreements with healthcare professionals and institutions that prescribe these targeted therapies to patients. While specific pricing plans for the products are not publicly detailed, the company is expected to implement a structured approach to pricing that reflects the unique value and clinical outcomes associated with its innovative treatments. The company is focusing on expanding its product line and aims to enter new markets, with specific plans targeting regions with high unmet medical needs for ophthalmic therapies.
Who invested in Nacuity Pharmaceuticals
3 investors across 1 round
See all investors in Nacuity Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 15, 2022
Amount
$17M
Investors
Questions about Nacuity Pharmaceuticals
Who invested in Nacuity Pharmaceuticals?
Nacuity Pharmaceuticals has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nacuity Pharmaceuticals raised?
Nacuity Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nacuity Pharmaceuticals last raise money?
Nacuity Pharmaceuticals's most recent round on record is a Series B, in Jun 2022.
What does Nacuity Pharmaceuticals do?
Nacuity Pharmaceuticals is a pharmaceuticals company.
Where is Nacuity Pharmaceuticals headquartered?
Nacuity Pharmaceuticals is headquartered in Fort Worth, US.
Which VCs invest in companies like Nacuity Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Nacuity Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Nacuity Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.